by Neoteryx, on Jul 6, 2020 9:00:00 AM
The COVID-19 pandemic is lingering a little longer than we expected. The pandemic has dramatically impacted health institutions and other organizations, requiring them to restructure and redefine their practices in …
Read Storyby Neoteryx, on May 4, 2020 9:30:00 AM
A growing need for patients to take a more proactive role in their health has led to recent trends in "patient-centric medicine" and "telehealth." Healthcare providers who need to monitor …
Read Storyby Neoteryx, on Jan 28, 2020 3:12:00 AM
When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, …
Read Storyby Neoteryx, on Jan 14, 2020 4:43:00 AM
Therapeutic drug monitoring (TDM) immunosuppressants are a critical component of post-tissue and organ transplantation therapy. This is because ISP drugs have high intra- and inter-subject variability and a narrow therapeutic …
Read Storyby Neoteryx, on Jan 6, 2020 2:52:00 AM
When administering immunosuppressants, clinicians need to individualize a patient’s drug therapy. The goal is to attain an optimal balance between therapeutic efficacy and the probability of adverse effects. Patients present …
Read Storyby Neoteryx, on Dec 9, 2019 4:46:00 AM
Patient-centric healthcare has taken center-stage. With the increasing access to information, patients want to play a role in treatment methods and applications. Patient-centric sampling has an important part to play …
Read Story